KR101480690B1 - Oral composition containing natural agent - Google Patents

Oral composition containing natural agent Download PDF

Info

Publication number
KR101480690B1
KR101480690B1 KR20080086780A KR20080086780A KR101480690B1 KR 101480690 B1 KR101480690 B1 KR 101480690B1 KR 20080086780 A KR20080086780 A KR 20080086780A KR 20080086780 A KR20080086780 A KR 20080086780A KR 101480690 B1 KR101480690 B1 KR 101480690B1
Authority
KR
South Korea
Prior art keywords
extract
composition
oral
salt
pine needle
Prior art date
Application number
KR20080086780A
Other languages
Korean (ko)
Other versions
KR20100027746A (en
Inventor
이병렬
김찬호
김기정
Original Assignee
(주)아모레퍼시픽
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)아모레퍼시픽 filed Critical (주)아모레퍼시픽
Priority to KR20080086780A priority Critical patent/KR101480690B1/en
Publication of KR20100027746A publication Critical patent/KR20100027746A/en
Application granted granted Critical
Publication of KR101480690B1 publication Critical patent/KR101480690B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755Gymnosperms [Coniferophyta]
    • A61K8/9767Pinaceae [Pine family], e.g. pine or cedar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/15Pinaceae (Pine family), e.g. pine or cedar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • A61K36/328Commiphora, e.g. mecca myrrh or balm of Gilead
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 솔잎추출물 및 몰약추출물을 함유하는 구강용 조성물에 관한 것으로, 보다 상세하게는 구강내 세균을 효과적으로 제어할 수 있도록 항균력이 우수한 솔잎추출물과 몰약추출물을 함유하여 구취 제거를 특징으로 하는 구강용 조성물에 관한 것이다. 또한 본 발명은 상기 조성물에 소금을 더 함유하는 구강용 조성물에 관한 것이다. 본 발명에 따른 구강용 조성물은 솔잎추출물과 몰약추출물의 항균 시너지 효과 및 소금의 잇몸에 대한 수렴효과에 의해, 구강내 세균을 억제시켜 구취를 제거하고, 잇몸질환의 예방효과가 탁월하며, 양치 후 상쾌함 및 개운함을 장시간 유지시킬 수 있다.The present invention relates to an oral composition containing pine needle extract and myrrh extract. More particularly, the present invention relates to a composition for oral cavity containing a pine needle extract and a myrrh extract excellent in antibacterial activity so as to effectively control germs in the mouth, ≪ / RTI > The present invention also relates to an oral composition further comprising a salt in said composition. The composition for oral use according to the present invention is effective for preventing gum disease by suppressing bacteria in the oral cavity by the synergy effect of pine needle leaf extract and myrrh extract and the convergence effect of salt on the gum, The freshness and freshness can be maintained for a long time.

솔잎추출물, 몰약추출물, 소금, 구취제거, 잇몸질환예방, 구강용 조성물 Pine needle extract, myrrh extract, salt, bad breath removal, prevention of gum disease, oral composition

Description

천연 추출물을 함유한 구강용 조성물{Oral composition containing natural agent}[0001] The present invention relates to an oral composition containing natural agent,

본 발명은 솔잎추출물 및 몰약추출물을 함유하는 구강용 조성물, 및 상기 조성물에 소금을 더 함유하는 구강용 조성물에 관한 것으로, 보다 상세하게는 구강내 세균을 효과적으로 제어할 수 있도록 항균력이 우수한 솔잎추출물과 몰약추출물, 및 잇몸질환에 효과가 있는 소금을 함유하는 구강용 조성물에 관한 것이다.The present invention relates to an oral composition containing pine needle extract and myrrh extract, and a composition for oral use which further contains salt in the composition. More particularly, the present invention relates to an oral composition comprising pine needle extract Myrrh extract, and salt which is effective for gum disease.

일반적으로 구강내에서 발생하는 구취는 통상 황성분이 포함된 단백질과 펩타이드가 염기성 환경하에서 그람 음성 세균에 의해 가수분해되면서 생성된다. 이 과정을 통해서 발생하는 황화합물은 황화수소, 메틸머캅탄, 다이메틸 설파이드 등이다. 그람 양성 세균이 우세한 환경이 그람 음성과 혐기성 세균이 우세한 환경으로 전환되는 것이 냄새 발생과 관련이 있다. 타액 분비량이 감소한다거나 구강내 pH가 상승하는 것과 같은 구소적 요인이 이런 전환과정에 영향을 미칠 수 있다. 치간에 존재하는 세균막을 효과적이고 지속적으로 제거하지 못하면 그곳에 남아 있는 그람 음성 세균이 황을 포함하는 아미노산을 분해해 결과적으로 냄새가 발생할 수 있다. 염증 진행과정에서 생성되는 기질은 세균 성장을 촉진하기 때문에 치주염도 구취발생에 기여요인이 될 수 있다. 또한 부패과정과 그에 동반하는 악취발생은 혀에 세균이 많이 축적되어 있을 때 더욱 빠르게 진행된다. 치주염이 진행되고 치주낭이 깊어지는 것도 구취발생에 기여한다. 그러므로 치주염의 관리는 구치를 관리하는 데 중요한 부분이다. Generally, halitosis in the oral cavity is usually produced by hydrolysis of proteins and peptides containing sulfur components by Gram-negative bacteria in a basic environment. The sulfur compounds generated through this process are hydrogen sulfide, methyl mercaptan, dimethyl sulfide, and the like. It is related to the occurrence of smell that the environment in which Gram positive bacteria predominate is converted into an environment in which Gram negative and anaerobic bacteria predominate. Positional factors such as decreased saliva secretion or increased oral pH may affect this conversion process. If the bacteria membrane present in the interdental space can not be removed effectively and continuously, the gram-negative bacteria remaining therein may degrade the amino acid including sulfur, resulting in smell. Periodontitis also contributes to the development of halitosis, since the substrate produced during the inflammatory process promotes bacterial growth. In addition, the process of corruption and the accompanying odor are accelerated when the bacteria accumulate in the tongue. Progression of periodontal disease and deepening of the periodontal pouch contribute to the development of bad breath. Therefore, the management of periodontitis is an important part of managing posterior teeth.

따라서 구취제거 효과가 장기간 유지되기 위해서는 구취의 원인이 되는 구강 내 세균을 살균하여 구취발생을 근원적으로 방지할 필요가 있다.Therefore, in order to maintain the bad breath removal effect for a long period of time, it is necessary to sterilize the bacteria in the mouth, which causes bad breath, to fundamentally prevent bad breath.

구취 외에 일반적인 구강질환으로 충치 및 치주질환은 타액이 치면에 묻어 끈적한 얇은 막을 형성하고, 여기에 구강 미생물이 붙어 군락을 형성하여 생성된 프라그에 의해 일어나는 것으로 알려져 있다. 즉, 충치는 프라그 내의 혐기성 세균이 당류를 대사하여 생성한 유기산에 의해 치아의 주성분인 하이드록시아파타이트(Hydroxyapatite)가 녹아 발생하는 에나멜의 부식에 의해 일어나며, 치주질환은 숙주 방어능력을 초과한 프라그의 축적과 이에 따른 세균활성의 증가와 숙주 방어 능력의 약화가 함께 동반되어 일어난다. 그러므로 치주질환을 완화하려면 치주병인균의 활성을 억제하여, 잇몸에 발생한 염증을 완화하여야 한다.It is known that tooth decay and periodontal disease are caused by plaque that is formed by the formation of a thin film that sticks to the tooth surface of saliva and attaches oral microorganisms to the community to form a community. That is, the tooth decay is caused by the corrosion of the enamel which is generated by dissolving the hydroxyapatite, which is the main component of the teeth, by the organic acid produced by the anaerobic bacteria in the prage which metabolizes the saccharide, and the periodontal disease is caused by the Accumulation, resulting in increased bacterial activity and weakening of host defense capacity. Therefore, in order to alleviate periodontal disease, the activity of periodontal bacteria should be inhibited to relieve inflammation of the gums.

이러한 구강내 유해균을 살균하기 위하여 세틸피리디늄클로라이드, 염산클로로헥시딘 등 각종 살균제를 배합한 구강 제품이 공지되어 있지만 염산클로로헥시딘은 치아 변색을 야기시키는 단점이 있고, 세틸피리디늄은클로라이드는 양이온을 띠고 있는 화합물로서 음이온성 물질과의 강한 반응성 때문에 실제 사용시 구강 내 환경에 따라 효과가 반감되는 경우가 발생한다.Oral products containing various bactericides such as cetylpyridinium chloride and chlorohexidine hydrochloride are known to sterilize such oral bacteria, but chlorhexidine hydrochloride has a disadvantage of causing tooth discoloration, and cetylpyridinium is a chloride Is a cationic compound and its effect on the oral environment is reduced by half due to its strong reactivity with anionic substances.

그리고, 소금이 구강에 미치는 효과를 살펴보면, 일반적으로 소금을 구강에서 사용할 경우 잇몸에 대한 수렴 작용으로 구강 내 질환, 특히 치육염, 치조농루 등의 잇몸질환을 예방하거나 치료하는데 유효한 것으로 알려져 있어 종래에 이러한 잇몸질환의 예방 및 치료를 목적으로 소금을 배합한 구강용 조성물이 다수 제안되어 있다. The effect of salt on the oral cavity is generally known to be effective in preventing or treating gum diseases such as dental diseases, especially dental caries, and dental caries, due to the convergence action on the gums when the salt is used in the oral cavity. A number of oral compositions containing salt for the purpose of prevention and treatment of such gum disease have been proposed.

따라서 본 발명은 구강내 세균을 효과적으로 살균하여 뛰어난 구취제거 효과를 나타내고, 아울러 잇몸질환에 효과가 있는 구강용 조성물을 제공하는 것을 목적으로 한다.Accordingly, it is an object of the present invention to provide an oral composition which effectively sterilizes germs in the mouth to exhibit excellent bad breath removing effect and is effective for gum disease.

상기한 목적을 달성하기 위하여, 본 발명은 솔잎추출물 및 몰약추출물을 함유하는 구강용 조성물을 제공한다.In order to attain the above object, the present invention provides an oral composition containing pine needle extract and myrrh extract.

또한, 본 발명은 상기 조성물에 소금을 더 함유함을 특징으로 하는 구강용 조성물을 제공한다.The present invention also provides an oral composition characterized by further comprising a salt in the composition.

본 발명에 의해 제조된 구강용 조성물은 장단기간에 걸쳐 우수한 구취제거 효과를 제공하고, 구강 내에서 우수한 잇몸질환 예방 효과, 충치예방 효과 등을 제공할 수 있다.The composition for oral use according to the present invention can provide excellent halitosis removal effect over a long term and can provide excellent gum disease prevention effect and tooth decay prevention effect in the oral cavity.

본 발명의 구강용 조성물은 살균 및 항균성분으로서 솔잎추출물과 몰약추출물을 함유한다.The oral composition of the present invention contains a pine needle extract and a myrrh extract as bactericidal and antibacterial components.

또한, 본 발명의 구강용 조성물은 상기 조성물에 잇몸질환예방성분으로서 소금을 더 함유한다.In addition, the composition for oral use of the present invention further contains salt as a component for preventing gum disease.

이하 본 발명의 구강용 조성물의 제조에 관하여 설명한다.Hereinafter, the preparation of the oral composition of the present invention will be described.

본 발명에 사용되는 솔잎추출물은 다음과 같다. The pine needle extract used in the present invention is as follows.

소나무는 파이너스(Pinus)속으로 세계에 약 80-90종이 있으며 이들에서 채취한 테르펜 등이 주로 산업에 이용되고 있다. 솔잎의 주요성분은 터펜틴 오일(Terpenetine oil), 시네올(Cineole), 살리니그린(Salinigrin), 코니페린(Coniferin), 피-사이멘(P-Cymen), 덴시피마릭산(Densipimaric acid), 레텐(Retene)등과 엽록소, 단백질, 조지방, 인, 철분, 효소, 미네랄, 지용성 비타민 A 및 비타민 C 등도 함유되어 있으며, 솔잎에 함유되어 있는 주요성분은 각 종과 채취한 계절에 따라서 다소 차이가 있다. 터펜틴 오일은 휘발성 향기물질로 C10H16의 화학식을 갖는 불포화탄화수소의 일군이며 미생물에 대한 살균 및 항균작용이 알려져 있다.Pine trees are about 80-90 species in Pinus, and their terpenes are mainly used in industry. The major components of pine needles are terpenetine oil, Cineole, Salinigrin, Coniferin, P-Cymen, Densipimaric acid, Retene contains chlorophyll, protein, crude fat, phosphorus, iron, enzyme, minerals, fat soluble vitamin A and vitamin C. The major components of pine needles are different depending on the species and season . Turpentine oil is a volatile fragrance material, a group of unsaturated hydrocarbons having the chemical formula of C 10 H 16 , and the sterilization and antibacterial action against microorganisms is known.

소나무의 잎과 여린 가지에서 스팀증류로 추출한 솔잎정유의 주요성분은 모노테르펜(Monoterpenes), 세스퀴테르펜(Sesquiterpenes)이고, 모노테르펜 중에는 알파-피넨(α-Pinene)과 베타-피넨(β-Pinene), 카렌(Carene), 베타-미르센(β -Myrcene), 리모넨(Limonene) 등의 성분들이 함유되어 있다.Monoterpenes and Sesquiterpenes are the main components of pine needles extracted from steamed distillation from leaves and branches of pine trees. Among monoterpenes, α-Pinene and β-Pinene ), Carene, β-Myrcene, Limonene, and others.

또한 소나무는 예로부터 우리 민족의 실생활과 매우 밀접한 관계를 맺고 있다. 특히 솔잎은 다른 부분에 비해 채취가 쉽고 조제도 간편하여 가장 널리 이용되고 있다. 실제로 솔잎에는 일반 영양 성분, 아미노산과 지방산, 비타민, 무기질 등이 풍부하게 들어있어 솔잎분말이 건강식으로 판매되고 있다. 현재 솔잎은 녹즙, 술, 단물약, 달임물, 차, 과자나 건강 음료 등으로 다양하게 이용되고 있다.In addition, the pine has been closely related to the real life of our nation. Pine needles are most widely used because they are easier to take and easier to prepare than other parts. In fact, pine leaves contain common nutrients, amino acids, fatty acids, vitamins, and minerals. Currently pine leaves are widely used as green juice, alcohol, sweet potato, moon, tea, confectionary and health drink.

이러한 솔잎은 경험의학적으로 각종 약효가 발휘된다고 알려져 민간요법으로 사용되어 왔다. 그 중에 구강질환과 관련하여 구취에는 솔잎을 물에 씻어 몇 개를 씹는다고 하였고, 구내염에는 송엽액을 탈지면에 묻혀 환부에 바른다고 하였다. 그밖에 치통에는 솔잎을 끓인 물로 양치질을 하고, 잇몸이 부은 데는 솔잎을 졸인 것에 소금을 넣어 입에 한참 물고 있고, 아구창에는 솔잎을 한 줌 달여서 그 즙을 입안에 물었다가 양치질을 하며, 치조농루에는 솔잎 졸인 물로 양치질을 하면 효과가 있다고 하였다.These pine leaves have been used as folk remedies because they have been known to exert various medicinal effects in empirical medicine. In relation to oral diseases, it was said that the bad poultry was washed in water and chewed a few. In the stomatitis, it was said that the pine bark liquid was put on the skin and put on the affected part. In addition, toothpastes brush the pine needles with boiled water, and when the gums are poured, they put salt into the pine needle for a long time, and in the thrush, the pine needles are dipped in a handful of fingers to bite their juices in their mouths. It was said that brushing with water was effective.

본 발명에 사용한 솔잎추출물은 본 발명이 속하는 기술분야에 공지된 통상의 방법으로 제조된 것을 사용할 수 있으며, 바람직하게는 채취한 솔잎을 1.0~2.0cm 크기로 절단한 것 50g에 70% 에탄올 용액(물과 에탄올의 혼액)을 500ml의 비율로 가하여 실온에서 7일간 침적하여 추출, 여과한 후 그 여과액을 감압 농축하여 농축물을 얻는다.The pine leaf extract used in the present invention may be those prepared by conventional methods known in the art. Preferably, 50% of the pine leaves obtained by cutting the collected pine leaves to a size of 1.0 to 2.0 cm is dissolved in 70% ethanol solution Water and ethanol) is added in a ratio of 500 ml, and the mixture is dipped in water at room temperature for 7 days to extract and filter. The filtrate is concentrated under reduced pressure to obtain a concentrate.

본 발명에 사용되는 몰약추출물은 다음과 같다.The myrrh extract used in the present invention is as follows.

몰약은 미르라(myrrha)라고도 하며, 염료에 사용되는 화몰약(花沒藥)과 구별 하기 위하여 연몰약(練沒藥)이라고도 한다. 담황색 또는 암갈색의 크고 작은 덩어리 물질로서 알코올에 녹여 미르라팅크로서 구중향료(口中香料)에 사용한다. 정유(精油) ·수지 ·고무질을 함유한다. 방부제로서 예전부터 사용되었고, 특히 미라를 만들 때 많이 쓰인 것은 널리 알려진 사실이다. 또 신약성서 <마태오의 복음서>(2:11)에서 동방박사가 아기예수에게 유향 ·황금과 함께 드린 것으로도 잘 알려져 있다.Myrrh is also known as myrrha, also known as 药, to distinguish it from the flower manganese used in dyes. It is a pale yellow or dark brown lump material which is dissolved in alcohol and used as a myrrh tincture in the fragrance of mouth. Contains essential oils, resins, and gums. It has long been used as a preservative, and it is a widely known fact that it has been used extensively in making mummies. In the New Testament, the Gospel of Matthew (2:11), it is well known that the Magi was given to the baby Jesus with frankincense and gold.

이러한 몰약은 Commphora molmol Engl. 및 동속식물(감람나무과 Burseraceae)의 껍질부위의 상처에서 얻은 고무수지로 진통, 방부작용이 있어 아구창, 치은염 및 구강세제에 사용되어 왔다.These myrrhs are commercially available from Commphora molmol Engl. And rubbery resin from the scars of the bark area of the plant (Olive and Burseraceae) have been used for thrush, gingivitis, and mouthwashes due to side effects such as pain and nausea.

본 발명에 사용한 몰약추출물은 본 발명이 속하는 기술분야에 공지된 통상의 방법으로 제조된 것을 사용할 수 있으며, 바람직하게는 Commphora 종(species)의 천연 올레오 검 레진(Oleo-gum-resin) 1kg을 잘게 부수고, 수증기를 1.5kg/cm2의 압력하에서 0.5L/min의 속도로 2시간 흘려 보낸 다음 흘러나온 수증기를 냉각기를 통과시켜 냉각시킨 뒤, 수기플라스크에 모아진 추출물을 물층으로부터 분리하여 90g의 추출물을 얻는다. 여기에 식용에탄을을 추출물 농도가 50%가 되도록 넣어 혼화하여 얻는다.The myrrh extract used in the present invention may be one prepared by a conventional method known in the art, preferably 1 kg of Commele species of Oleo-gum-resin The water vapor was flowed at a rate of 0.5 L / min under a pressure of 1.5 kg / cm 2 for 2 hours, and then the water vapor, which flowed out, was cooled by passing through a cooler. Then, the collected extract was separated from the water layer, . The edible ethane is obtained by mixing with 50% extract concentration.

본 발명에 사용되는 소금은 종류가 한정되는 것은 아니지만, 바람직하게는 천일염, 정제염, 구운소금 등을 사용한다.The type of salt used in the present invention is not limited, but preferably used are sun salt, refined salt, baked salt and the like.

본 발명의 구강용 조성물은 상기와 같은 방법으로 얻은 솔잎추출물을 조성물 총 중량에 대하여 0.001~2.0중량%, 몰약추출물을 조성물 총 중량에 대하여 0.001~2.0중량%의 양으로 함유하며, 여기에 소금을 조성물 총 중량에 대하여 0.001~10.0중량%의 양으로 더 함유할 수 있다. The oral composition of the present invention contains 0.001 to 2.0% by weight of the pine needle extract obtained by the above-mentioned method in the total weight of the composition and the myrrh extract in an amount of 0.001 to 2.0% by weight based on the total weight of the composition. Based on the total weight of the composition, in an amount of 0.001 to 10.0% by weight.

본 발명의 구강용 조성물은 솔잎추출물 및 몰약추출물의 상승효과에 의하여 구강 내 세균을 억제시키는 항균작용 및 구취감소 효과가 탁월하며, 소금의 잇몸에 대한 수렴효과에 의해 치주질환예방효과를 제공한다.The oral composition of the present invention is excellent in antimicrobial activity and halitosis reduction effect for inhibiting bacteria in oral cavity by the synergy effect of pine leaf extract and myrrh extract, and provides a preventive effect of periodontal disease by convergence effect of salt on gums.

본 발명의 구강용 조성물은 그 제형에 있어서 특별히 한정되지 않으며, 구체적으로는 치약, 구강세정제 또는 구강청정제 등의 제형을 가질 수 있다.The composition for oral use of the present invention is not particularly limited in its formulation, and may specifically include a formulation such as a toothpaste, mouthwash or mouthwash.

본 발명에 사용되는 구강용 조성물의 배합 성분은 위에서 기술한 솔잎추출몰, 몰약추출물 및 소금 외에도 조성물의 용도와 종류에 따라 변경된다.The compounding ingredients of the oral composition for use in the present invention may be varied depending on the use and the kind of the composition, in addition to the above-described pine extract mall, myrrh extract and salt.

본 발명에서 실시하기 위한 각종 구강용 조성물은 그 종류에 따라 적당한 성분을 사용할 수 있으며, 예를 들면 제형이 치약인 경우 통상적인 치약성분들로서 연마제, 습윤제, 기포제, 결합제, 감미제, pH조절제, 방부제, 약효성분, 향료, 증백제, 색소, 용제 등을 함유할 수 있다. The composition for oral use according to the present invention may be appropriately selected depending on the type of toothpaste. For example, when the formulation is toothpaste, common dentifrice ingredients include abrasives, wetting agents, foaming agents, binders, sweeteners, pH adjusting agents, preservatives, A perfume, a brightener, a pigment, a solvent and the like.

연마제로는 탄산칼슘, 침강 실리카, 수산화알루미늄, 인산일수소칼슘, 불용성 메타인산나트륨 등이 있으며, 이들 연마제를 단독 혹은 2종 이상 혼합하여 조성물 총 중량에 대하여 1~60중량%, 바람직하게는 10~50중량%를 사용한다. Examples of the abrasive include calcium carbonate, precipitated silica, aluminum hydroxide, calcium monohydrogenphosphate and insoluble sodium metaphosphate. These abrasives may be used alone or in admixture of two or more in an amount of 1 to 60% by weight, preferably 10 To 50% by weight.

습윤제로서는 글리세린, 소르비톨액, 폴리에틸렌글리콜, 프로필렌글리콜 등 을 단독 혹은 2종 이상 혼합하여 조성물 총 중량에 대하여 10~60중량%, 바람직하게는 20~50중량%를 사용한다. 기포제로는 라우릴황산나트륨, 소디움라우릴사르코시네이트, 자당지방산에스테르, 폴리옥시에틸렌경화피마자유, 폴리옥시에틸렌폴리옥시프로필렌 공중합체 등의 음이온 및 비이온 계면활성제를 단독 혹은 2종 이상 혼합하여 조성물 총 중량에 대하여 0.5~5중량%, 바람직하게는 0.5~3중량%를 사용한다. As the wetting agent, glycerin, sorbitol solution, polyethylene glycol, propylene glycol, etc. are used singly or in admixture of two or more, and 10 to 60% by weight, preferably 20 to 50% by weight, based on the total weight of the composition. Examples of the foaming agent include anionic and nonionic surfactants such as sodium lauryl sulfate, sodium lauryl sarcosinate, sucrose fatty acid ester, polyoxyethylene hydrogenated castor oil, and polyoxyethylene polyoxypropylene copolymer. 0.5 to 5% by weight, preferably 0.5 to 3% by weight, based on the total weight is used.

결합제로서는 카르복시메틸 셀룰로오스 나트륨, 하이드록시메틸셀룰로오스, 카라기난, 잔탄검, 알긴산 나트륨 등을 단독 혹은 2종 이상 혼합하여 조성물 총 중량에 대하여 0.1~5중량%, 바람직하게는 0.1~2중량%를 사용한다. 감미제로는 사카린나트륨, 아스파탐, 스테비오사이드, 자이리톨, 감초산 등을 단독 혹은 2종 이상 혼합하여 조성물 총 중량에 대하여 0.05~5중량%를 사용하는 것이 좋다. As the binder, 0.1 to 5% by weight, preferably 0.1 to 2% by weight, based on the total weight of the composition, of carboxymethylcellulose sodium, hydroxymethylcellulose, carrageenan, xanthan gum and sodium alginate are used alone or in combination of two or more thereof . As the sweetening agent, it is preferable to use 0.05 to 5% by weight based on the total weight of the composition of sodium saccharin, aspartame, stevioside, xylitol, licorice acid, etc., alone or in admixture of two or more.

pH조절제로는 인산나트륨, 인산이나트륨, 인산삼나트륨, 피로인산나트륨, 구연산, 구연산나트륨, 주석산 등이 있고, 방부제로는 파라옥시안식향산메틸, 파라옥시안식향산프로필, 안식향산나트륨을 단독 혹은 2종 이상 혼합하여 사용한다. Examples of the pH adjusting agent include sodium phosphate, disodium phosphate, trisodium phosphate, sodium pyrophosphate, citric acid, sodium citrate and tartaric acid. Examples of the preservative include methylparabenoxybenzoate, propylparabenoxybenzoate, sodium benzoate, Mix and use.

약효성분으로는 불화나트륨, 일불소인산나트륨, 불화주석, 클로로헥시딘, 알란토인클로로히드록시알루미네이트, 아미노카프론산, 트라넥사민산, 트리클로산, 염화세틸피리디움, 염화아연, 염산피리독신, 초산토코페롤 등을 단독 혹은 2종 이상 혼합하여 사용하고, 향료로는 페퍼민트오일, 스피아민트오일, 멘톨, 아네톨 등을 적당량 혼합사용하며, 증백제로는 산화티탄을, 색소로는 식용색소를, 정제수 및 에탄올의 용제로 통상의 치약 제조방법에 따라 제조한다.Examples of the active ingredient include sodium fluoride, sodium fluorophosphate, tin fluoride, chlorohexidine, allantoin chlorohydroxy aluminate, aminocaproic acid, tranexamic acid, triclosan, cetylpyridinium chloride, zinc chloride, pyridoxine hydrochloride, Tocopherol and the like may be used alone or in admixture of two or more. Examples of the perfume include a mixture of peppermint oil, spearmint oil, menthol, anethole, etc. in an appropriate amount, titanium oxide as a brightener, It is a solvent for ethanol and is prepared according to the usual toothpaste manufacturing method.

이하, 실시예 및 비교예를 들어 본 발명에 따른 구강용 조성물의 구성 및 작용효과에 대해 보다 구체적으로 설명한다. 그러나, 본 발명이 이들 예로만 한정되는 것은 아니다. Hereinafter, the composition and action and effect of the oral composition according to the present invention will be described in more detail with reference to Examples and Comparative Examples. However, the present invention is not limited to these examples.

[실시예 및 비교예] [Examples and Comparative Examples]

하기 표 1의 조성으로 통상의 제조방법에 따라 실시예 1~2 및 비교예 1~3의 치약을 제조하였다.Toothpastes of Examples 1 to 2 and Comparative Examples 1 to 3 were prepared according to a conventional production method with the composition shown in Table 1 below.

성 분ingredient 실시예1Example 1 실시예2Example 2 비교예1Comparative Example 1 비교예2Comparative Example 2 비교예3Comparative Example 3 불화나트륨Sodium fluoride 0.300.30 0.300.30 0.300.30 0.300.30 0.300.30 침강실리카Precipitated silica 17.0017.00 17.0017.00 17.0017.00 17.0017.00 17.0017.00 솔잎추출물Pine leaf extract 0.100.10 0.100.10 0.100.10 -- 몰약추출물Myrrh extract 0.100.10 0.100.10 -- -- 0.100.10 정제염Purified salt 1.001.00 농글리세린Concentrated glycerin 3.003.00 3.003.00 3.003.00 3.003.00 3.003.00 소르비톨액Sorbitol solution 10.0010.00 10.0010.00 10.0010.00 10.0010.00 10.0010.00 카르복시메칠셀룰로오스나트륨Sodium carboxymethylcellulose 1.001.00 1.001.00 1.001.00 1.001.00 1.001.00 삭카린나트륨Sodium saccharin 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 파라옥시안식향산메칠Paraoxybenzoic acid methyl 0.200.20 0.200.20 0.200.20 0.200.20 0.200.20 산화티탄Titanium oxide 0.100.10 0.100.10 0.100.10 0.100.10 0.100.10 향료Spices 1.001.00 1.001.00 1.001.00 1.001.00 1.001.00 라우릴황산나트륨Sodium lauryl sulfate 2.002.00 2.002.00 2.002.00 2.002.00 2.002.00 정제수Purified water To 100To 100 To 100To 100 To 100To 100 To 100To 100 To 100To 100

[시험예 1] 항균력 비교시험[Test Example 1] Comparison test of antibacterial activity

상기 실시예 1과 비교예1~3을 1:20에서 1:5120까지 희석한 시험액 2ml과 혈액 한천 배지(혈액 한천 베이스 + 최종 농도 5%의 양 혈액) 18ml를 9cm 페트리접시(petri dish)에 부었다. 그 후 시험균을 접종하고, 혐기성 챔버(anaerobic chamber)를 이용하여 37℃에서 96시간 배양하였다. 시험균이 자라지 않는 최대희석비율을 MID로 하였으며(Bactron I. anaerobic chamber를 사용), 세균발육억제 최대희석비율(MID)는 하기 표 2에 나타내었다.2 ml of the test solution diluted from 1: 20 to 1: 5120 in Example 1 and Comparative Examples 1 to 3 and 18 ml of the blood agar medium (blood agar base + 5% final concentration blood) were placed in a 9 cm petri dish Poured. After that, the test bacteria were inoculated and cultured in an anaerobic chamber at 37 ° C for 96 hours. The maximum dilution ratio (MID) for which the test bacteria did not grow was designated as MID (using Bactron I. anaerobic chamber), and the maximum dilution ratio (MID) for inhibiting bacterial growth is shown in Table 2 below.

<시험균><Test bacteria>

① 구취원인균 : Fusobacterium nucleatum ATCC 25586, Porphyromonas gingivalis ATCC 33277① Bad breath causative bacteria: Fusobacterium nucleatum ATCC 25586, Porphyromonas gingivalis ATCC 33277

② 충치원인균 : Streptococcus mutans NCTC 10449, Actinomyces viscosus ATCC 15987② Cariogenic bacteria: Streptococcus mutans NCTC 10449, Actinomyces viscosus ATCC 15987

③ 주질환 원인균 : Actionbacillus actinomycetemcomitans ATCC 29522③ Main disease causing bacteria: Actionbacillus actinomycetemcomitans ATCC 29522

세균발육억제 최대희석비율(MID)Bacterial growth inhibition Maximum dilution rate (MID) 시험균Test bacteria 실시예 1Example 1 비교예 1Comparative Example 1 비교예 2Comparative Example 2 비교예 3Comparative Example 3 FusobacteriumFusobacterium nucleatumnucleatum 25602560 >20> 20 160160 320320 PorphyromonasPorphyromonas gingivalisgingivalis 25602560 >20> 20 320320 160160 StreptococcusStreptococcus mutansmutans 12801280 >20> 20 320320 640640 ActinomycesActinomyces viscosusviscosus 51205120 2020 640640 12801280 ActionbacillusActionbacillus
ActinomycetemcomitansActinomycetemcomitans
12801280 >20> 20 160160 160160

상기 표 2의 결과로부터 알 수 있듯이, 약효성분을 전혀 함유하고 있지 않은 비교예 1의 조성물은 구강유해균에 대한 억제효과가 거의 나타나지 않아 항균효과가 거의 없음을 나타내었고, 솔잎추출물을 함유한 비교예 2와 몰약추출물을 함유한 비교예 3은 비교예 1보다는 유효한 항균효과를 나타내었다. 그러나 솔잎추출물과 몰약추출물이 병용 사용된 실시예 1은 비교예 2 및 3과 비교하여 각종 구강유해균에 대하여 탁월한 항균효과를 나타냄을 알 수 있다. 이를 통해 솔잎추출물과 몰약추출물의 병용사용은 항균력 증가에 있어서 상승효과를 발휘함을 확인하였다. As can be seen from the results of Table 2, the composition of Comparative Example 1, which contained no active ingredient, exhibited almost no antimicrobial effect because the inhibitory effect on oral pest was not observed. In Comparative Example 1 containing pine needle extract 2 and mulberry extract in Comparative Example 3 showed more effective antibacterial effect than Comparative Example 1. However, it can be seen that Example 1, in which pine needle extract and myrrh extract are used in combination, shows an excellent antibacterial effect against various oral pest bacteria as compared with Comparative Examples 2 and 3. It was confirmed that the combined use of pine needle extract and myrrh extract showed synergistic effect in increasing the antibacterial activity.

[시험예 2] 타액내 세균수 측정[Test Example 2] Measurement of the number of bacteria in saliva

15㎖ 팔콘 튜브(Falcon tube)에 멸균된 0.1% 펩톤용액(0.9% NaCl 1000㎖ 에 펩톤(peptone) 1g을 첨가)을 5㎖씩 분주하여 40개를 준비한 후, 실험 대상자 40명에게 펩톤용액을 15초간 수구하게 한 후, 이 펩톤용액을 멸균된 0.067M 포스페이트 버퍼(Phosphate buffer) 용액(pH 7.2)으로 10배 희석하였다. 희석한 이 용액의 100㎕를 취하여 Mitis Salivarius 배지(Agar)에 분주하고, 멸균된 벤딩 유리(bending glass)로 평판에 전체적으로 도말한 다음, 37℃ 배양기에 12시간 배양 후, 혐기성 챔버(Anaerobic chamber)에서 37℃ 48시간 동안 다시 배양한 다음, 콜로니 카운터(Colony counter)를 이용해 각 배지에서 Streptococcus mutans의 콜로니(colony)를 측정하여 기록하였다. Streptococcus mutans의 콜로니(colony)는 현미경적 검사를 통하여 균의 종류를 확인하고, 표준균주 Streptococcus mutans NTCC 10449를 MSA에 같은 시간과 조건으로 배양한 후 콜로니의 형태를 확인하여, 실험대상자에서 Streptococcus mutans의 콜로니만을 선별하여 측정하였다. 실험 대상자 한사람 당, 희석된 펩톤수구액을 Mitis Salivarius 배지 평판 2개에 분주하여, 콜로니 측정을 1차, 2차 2회에 걸쳐 시행하여 두 측정의 평균값을 실험대상자의 Streptococcus mutans 수로 하였다. 측정한 결과는 하기 표 3에 나타내었다.40 ml of a 0.1% peptone solution (1000 ml of 0.9% NaCl and 1 g of peptone) was dispensed into each 15 ml Falcon tube in 5 ml aliquots, and then 40 peptone samples were subjected to a peptone solution After allowing to stand for 15 seconds, the peptone solution was diluted 10-fold with sterilized 0.067 M phosphate buffer solution (pH 7.2). 100 μl of the diluted solution was dispensed into Mitis Salivarius medium, plated on a flat plate with sterilized bending glass, and incubated in a 37 ° C incubator for 12 hours. Then, an anaerobic chamber At 37 &lt; [deg.] &Gt; C for 48 hours, and then cultured in each medium using a Colony counter Streptococcus The colony of mutans was measured and recorded. Streptococcus The colony of mutans was confirmed by microscopic examination and the strain Streptococcus mutans NTCC 10449 to check the form of the cultured colony in the time and under the same conditions as in the MSA, it was measured by selecting only the colonies of Streptococcus mutans in the test subjects. For each subject, diluted peptone juice was dispensed into two plates of Mitis Salivarius medium, and colonies were measured on the first and second occasions. The average value of the two measurements was taken as the number of Streptococcus mutans in the subjects. The measurement results are shown in Table 3 below.

타액내 세균수 측정Measurement of bacterial count in saliva 경과시간Elapsed time 실시예 1Example 1 비교예 1Comparative Example 1 비교예 2Comparative Example 2 비교예 3Comparative Example 3 실험직후Immediately after the experiment 109109 108108 110110 112112 2주후after 2 weeks 2121 9898 6565 5454

상기 표 3의 결과로부터 알 수 있듯이, 솔잎추출물과 몰약추출물을 전혀 함유하지 않은 비교예 1의 조성물은 Streptococcus mutans의 수가 거의 줄어들지 않았고, 솔잎추출물을 함유한 비교예 2나 몰약추출물을 함유한 비교예 3의 경우에는 비교예 1과 비교하여서는 수치가 떨어졌다. 그러나 솔잎추출물과 몰약추출물이 병용 사용된 실시예 1의 경우에는 비교예 2 및 3과 비교하여 탁월한 결과를 나타냄을 알 수 있다. 이것으로부터 솔잎추출물과 몰약추출물의 병용 사용이 상승효과로 인하여 세균 수를 매우 크게 감소시키는데 효과적임을 확인하였다. As can be seen from the results in Table 3, the composition of Comparative Example 1, which contained no pine needle extract and myrrh extract, was Streptococcus the number of mutans was not substantially reduced, and in Comparative Example 2 containing pine needle extract or Comparative Example 3 containing myrrh extract, the values were lower than those of Comparative Example 1. However, it can be seen that Example 1, in which pine needle extract and myrrh extract are used together, shows excellent results as compared with Comparative Examples 2 and 3. From these results, it was confirmed that the combined use of pine needle extract and myrrh extract was effective in reducing the number of bacteria significantly due to the synergistic effect.

[시험예 3] 구취제거 효과측정[Test Example 3] Measuring effect of removing bad breath

실험대상자 80명에게 48시간 동안 일체의 구강환경관리를 중지시킨 후 할리메타로 구취정도를 측정한 다음 평균수치가 비슷하도록 4군으로 나누었다. 각각의 군에 대하여 실시예 1~2와 비교예 1~3을 시험양치액으로 양치하게 하였다. 양치 후 30분 경과시점에 다시 구취정도를 측정하였다. 이어서 28일간 각각의 시험양치액을 1일 2회씩 사용하도록 하였다. 7일, 14일, 21, 28일이 경과한 때에 소환하여, 양치 후 30분 경과시점에 다시 구취정도를 측정하였으며, 치약 조성물의 사용기간에 따른 구취감소효과는 하기 표 4에 나타내었다.Eighty subjects were stopped for 48 hours after halting the oral environment management and then halitosis was measured. For each group, Examples 1 to 2 and Comparative Examples 1 to 3 were soaked with a test rinse. The degree of bad breath was measured again 30 minutes after brushing. Then, each test tooth solution was used twice a day for 28 days. 7 days, 14 days, 21 days and 28 days after the brushing, and the degree of bad breath was measured again at the time of 30 minutes after brushing, and the reduction effect of the bad breath according to the use period of the toothpaste composition is shown in Table 4 below.

경과단계별 구취 점수Saliva score 경과시간Elapsed time 실시예1Example 1 실시예2Example 2 비교예 1Comparative Example 1 비교예 2Comparative Example 2 비교예 3Comparative Example 3 실험직후Immediately after the experiment 220220 220220 219219 218218 221221 7일7 days 170170 150150 222222 205205 208208 14일14 days 145145 130130 217217 196196 195195 21일21st 115115 103103 219219 185185 187187 28일28th 102102 9696 217217 174174 176176

상기 표 4의 결과를 보면, 약효성분을 전혀 사용하지 않은 비교예 1의 구강 조성물의 구취점수는 거의 변화가 없었다. 반면에 솔잎추출물과 몰약추출물을 병용 사용하는 실시예 1의 조성물의 구취점수는 현저하게 감소되었다. 솔잎추출물과 몰약추출물을 각각 사용하는 비교예 2 및 비교예 3의 경우에도 감소효과가 나타났지만, 병용 사용한 실시예 1과 비교해 볼 경우에 그 효과는 그다지 크지 않았다. 더욱이 솔잎추출물과 몰약추출물에 소금을 함께 사용한 실시예 2는 그 효과가 현저하게 차이가 있음을 확인할 수 있었다.The results of Table 4 show that the oral composition of Comparative Example 1, in which no active ingredient was used at all, showed almost no change in the odor score. On the other hand, the composition of Example 1 in which the pine needle extract and the myrrh extract were used in combination showed a significant decrease in the score of halitosis. In Comparative Example 2 and Comparative Example 3 in which the pine needle extract and myrrh extract were respectively used, a reduction effect was also exhibited, but the effect was not so large when compared with Example 1 used in combination. Furthermore, Example 2 using pine needle extract and myrrh extract together with salt could confirm that the effect was remarkably different.

[시험예 4] 잇몸질환 예방효과 측정[Test Example 4] Measurement of gum disease prevention effect

잇몸질환 예방효과를 확인하기 위해서 치은 지수를 측정하였으며, 그 방법은 다음과 같다. 먼저, 피검자 60명을 선별한 후 실험기간 동안 항생제의 복용과 실험에 영향을 미칠 수 있는 구강진료수취를 금하였다. 비교예 1 및 실시예 1~2 각각에 피검자를 20명씩 나누고 치은염 지수를 Talbott, Mandel and Chilton이 변형한

Figure 112008062725251-pat00001
의 치은염 평점 기준에 따라 측정하였다.The gingival index was measured to confirm the gum disease prevention effect, and the method was as follows. First, after screening 60 subjects, they were not allowed to take oral medications that could affect the antibiotic dosing and experimentation during the experimental period. Twenty subjects were each divided into Comparative Example 1 and Examples 1 and 2, and the gingival index was changed by Talbott, Mandel and Chilton
Figure 112008062725251-pat00001
Of gingivitis.

<Talbott, Mandel and Chilton이 변형한

Figure 112008062725251-pat00002
의 치은염 지수><Modified by Talbott, Mandel and Chilton
Figure 112008062725251-pat00002
Gingivitis Index>

Figure 112008062725251-pat00003
의 치은염평점기준
Figure 112008062725251-pat00003
Gingivitis Rating Criteria

0: 염증없음0: No inflammation

1: 경미 치은염(색조의 약한 변화 및 약한 부종) - 치주낭심측정시 출혈없음1: mild gingivitis (weak change of color tone and weak edema) - No bleeding in periodontal pouch

2: 중등 치은염(발적, 부종) - 치주낭심측정시 출혈2: Middle gingivitis (redness, edema) - Hemorrhage in measuring periodontal pouch

3: 고도 치은염(궤양) - 저절로 출혈되는 경향3: High grade gingivitis (ulcer) - tendency to bleed spontaneously

치은지수Gingival index 비교예 1Comparative Example 1 실시예 1Example 1 실시예 2Example 2 초기치Initial value 1.60±0.211.60 0.21 1.58±0.211.58 0.21 1.61±0.211.61 0.21 2주2 weeks 1.62±0.251.62 + - 0.25 1.32±0.221.32 ± 0.22 1.04±0.141.04 + - 0.14 4주4 weeks 1.59±0.221.59 ± 0.22 1.13±0.181.13 ± 0.18 0.72±0.160.72 ± 0.16 개선지수Improvement index 0.01±0.230.01 ± 0.23 0.45±0.200.45 ± 0.20 0.89±0.180.89 ± 0.18

표 5의 결과를 보면, 솔잎추출물과 몰약추추물 및 소금을 배합하지 않은 비교예 1은 치은염 완화 효과가 거의 없음을 알 수 있다. 솔잎추출물과 몰약추추물을 병용한 실시예 1의 경우에 어느 정도의 치은 개선 효과는 나타났지만, 소금을 치약에 배합한 실시예 2의 경우에 치은 개선 효과가 훨씬 더 뛰어났다. 이것은 소금의 잇몸에 대한 수렴작용으로 잇몸질환 예방효과를 훨씬 더 증가시키기 때문이다.The results of Table 5 show that Comparative Example 1, in which the pine needle extract, the myrrh extract and the salt were not blended, showed almost no gingival relaxation effect. In Example 1, in which the pine needle extract and the myrrh extract were used in combination, the gingival improvement effect was shown to some extent, but in the case of Example 2 in which the salt was added to the toothpaste, the gingival improvement effect was much better. This is because the concentration of salt on the gums causes the gum disease prevention effect to be further increased.

Claims (7)

솔잎추출물 및 몰약추출물을 함유하는 구강용 조성물.Pine needle extract and myrrh extract. 제 1항에 있어서, 상기 조성물은 소금을 더 함유함을 특징으로 하는 구강용 조성물.The oral composition of claim 1, wherein the composition further comprises salt. 제 1항에 있어서, 조성물 총 중량에 대하여 솔잎추출물은 0.001∼2.0중량%, 몰약추출물은 0.001∼2.0중량%의 양으로 함유됨을 특징으로 하는 구강용 조성물The oral composition according to claim 1, wherein the pine needle extract is contained in an amount of 0.001 to 2.0 wt% and the myrrh extract is contained in an amount of 0.001 to 2.0 wt% 제 2항에 있어서, 조성물 총 중량에 대하여 소금은 0.001~10.0중량%의 양으로 함유됨을 특징으로 하는 구강용 조성물.The oral composition according to claim 2, wherein the salt is contained in an amount of 0.001 to 10.0% by weight based on the total weight of the composition. 제 1항에 있어서, 상기 조성물은 항균작용이 있음을 특징으로 하는 구강용 조성물.The oral composition according to claim 1, wherein the composition has antibacterial activity. 제 1항 또는 제 2항에 있어서, 상기 조성물은 구취 제거를 특징으로 하는 구강용 조성물.3. The oral composition according to claim 1 or 2, wherein the composition is characterized by the removal of bad breath. 제 1항 또는 제 2항에 있어서, 상기 조성물은 치은염을 완화시키는 것을 특징으로 하는 구강용 조성물.The oral composition according to claim 1 or 2, wherein the composition alleviates gingivitis.
KR20080086780A 2008-09-03 2008-09-03 Oral composition containing natural agent KR101480690B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR20080086780A KR101480690B1 (en) 2008-09-03 2008-09-03 Oral composition containing natural agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20080086780A KR101480690B1 (en) 2008-09-03 2008-09-03 Oral composition containing natural agent

Publications (2)

Publication Number Publication Date
KR20100027746A KR20100027746A (en) 2010-03-11
KR101480690B1 true KR101480690B1 (en) 2015-01-09

Family

ID=42178677

Family Applications (1)

Application Number Title Priority Date Filing Date
KR20080086780A KR101480690B1 (en) 2008-09-03 2008-09-03 Oral composition containing natural agent

Country Status (1)

Country Link
KR (1) KR101480690B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190101300A (en) 2018-02-22 2019-08-30 주식회사 온엔온 Oral Composition Containing Natural Botanical Extracts and Manufacturing Method Thereof

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101882178B1 (en) * 2016-09-30 2018-07-26 노영수 Method for preparing surfactant-free gagle for oral hygiene using pine tree extract
KR102171798B1 (en) * 2018-02-02 2020-10-29 동의대학교 산학협력단 Composition for treating oral disease and inhibiting halitosis containing natural extracts and preparation method therefor
KR102109094B1 (en) * 2018-04-09 2020-05-11 동의대학교 산학협력단 A functional toothbrush for children
KR102147951B1 (en) * 2018-07-17 2020-08-25 조선대학교산학협력단 Antimicrobial composition against gram positive or gram negative bacteria containing extract of pine needle as effective component

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503541B1 (en) * 1999-06-10 2003-01-07 Pacific Corporation Method for preparation of plant extract powder oral compositions containing plant extract powder prepared by the same
KR20040081936A (en) * 2003-03-17 2004-09-23 동아제약주식회사 Dental composition for antiplaque and antigingivity
US20080031831A1 (en) 2005-10-21 2008-02-07 Technology & Marketing Consulting Oral anti-calculus compositions and methods of use thereof
KR20080027004A (en) * 2006-09-22 2008-03-26 (주)아모레퍼시픽 Method for the preparation of oral capsule and the oral composition containing the capsule powder prepared by the same

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503541B1 (en) * 1999-06-10 2003-01-07 Pacific Corporation Method for preparation of plant extract powder oral compositions containing plant extract powder prepared by the same
KR20040081936A (en) * 2003-03-17 2004-09-23 동아제약주식회사 Dental composition for antiplaque and antigingivity
US20080031831A1 (en) 2005-10-21 2008-02-07 Technology & Marketing Consulting Oral anti-calculus compositions and methods of use thereof
KR20080027004A (en) * 2006-09-22 2008-03-26 (주)아모레퍼시픽 Method for the preparation of oral capsule and the oral composition containing the capsule powder prepared by the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190101300A (en) 2018-02-22 2019-08-30 주식회사 온엔온 Oral Composition Containing Natural Botanical Extracts and Manufacturing Method Thereof

Also Published As

Publication number Publication date
KR20100027746A (en) 2010-03-11

Similar Documents

Publication Publication Date Title
CA2257596A1 (en) Antimicrobial agents for oral hygiene products
KR101480690B1 (en) Oral composition containing natural agent
KR101635861B1 (en) Oral composition containing fermentative extract of galla rhoids as active ingredient
KR102207872B1 (en) Oral composition for preventation or treatment of oral disease
KR20170103476A (en) Composition for prevention or treatment of oral disease comprising ROSAE LAEVIGATAE Extract
KR100637653B1 (en) Oral composition for inhibiting the halitosis
KR101703269B1 (en) Oral care composition comprising Magnolia officinalis extract and bicarbonate
KR101756306B1 (en) Oral composition containing extract of sapindus mukurossi Gaertn
KR20030089047A (en) Composition for enhancing oral health
KR101021787B1 (en) Oral composition having effects on periodontal disease and removing halitosis
KR20170037230A (en) Oral composition comprising cassava extract
KR102597684B1 (en) Oral composition comprising amaranth extract
KR100665891B1 (en) Oral hygiene compositions containing hydroxytyrosol
KR20020082308A (en) Composition for the mouth containing extraction of Euonymus alatus Sieb
KR102540804B1 (en) Composition containing Torreya nucifera extracts for preventing the formation of biofilm of mmicroorgaism
KR20170103482A (en) Composition for prevention or treatment of oral disease comprising Glechoma hederacea extract
KR20170103494A (en) Composition for prevention or treatment of oral disease comprising Melonis Pedicellus Extract
KR20240078208A (en) Composition for teeth whitening and antibacterial for oral microorganisms comprising apple extract
KR20170037231A (en) Oral composition comprising purslane extract
KR101818211B1 (en) Composition for prevention or treatment of oral disease comprising Arctill fructus Extract
KR102597685B1 (en) Oral composition comprising parsley extract
KR20240011429A (en) Oral care toothpaste composition containing herbal extract
KR20170142975A (en) Composition for prevention or treatment of oral disease comprising Leonurus sibiricus extract
KR20170103480A (en) Composition for prevention or treatment of oral disease comprising Kochiae Fructus Extract
KR20190124075A (en) Oral Composition containing Salix graciliglans Nakai extracts

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20190102

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20200102

Year of fee payment: 6